NDC 31722-627

Lacosamide

Lacosamide

Lacosamide is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is Lacosamide.

Product ID31722-627_e16676b2-5fe0-6f2d-e053-2995a90a1309
NDC31722-627
Product TypeHuman Prescription Drug
Proprietary NameLacosamide
Generic NameLacosamide
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2022-05-31
Marketing CategoryANDA /
Application NumberANDA209301
Labeler NameCamber Pharmaceuticals, Inc.
Substance NameLACOSAMIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 31722-627-26

1 BOTTLE in 1 CARTON (31722-627-26) > 200 mL in 1 BOTTLE
Marketing Start Date2022-05-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lacosamide" or generic name "Lacosamide"

NDCBrand NameGeneric Name
0121-0992LacosamideLacosamide
0121-1984LacosamideLacosamide
0121-2976LacosamideLacosamide
0121-3968LacosamideLacosamide
63850-0055LacosamideLacosamide
63850-0053LacosamideLacosamide
63850-0054LacosamideLacosamide
63850-0056LacosamideLacosamide
65162-912LacosamideLacosamide
0131-1810Vimpatlacosamide
0131-2470Vimpatlacosamide
0131-2477Vimpatlacosamide
0131-2478Vimpatlacosamide
0131-2479Vimpatlacosamide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.